MECLIZINE HYDROCHLORIDE by Novartis is h1 receptor. Approved for vertigo associated with diseases affecting the vestibular system in adults. First approved in 1976.
Drug data last refreshed 23h ago
H1 receptor.
Worked on MECLIZINE HYDROCHLORIDE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.